Tag: event-free survival

Complex aortic surgery shown safe with minimally invasive approach

Editor's Note Minimally invasive surgery can extend beyond valve replacement to complex aortic procedures without sacrificing safety or long-term outcomes. According to an August 21 news update from the University of Miami Miller School of Medicine, a new study of 796 patients found adding ascending aortic or hemiarch replacement to…

Read More

By: Tarsilla Moura
September 2, 2025
Share

Drug that makes tumors glow is transforming cancer surgery

Editor's Note A new drug is giving surgeons a sharper view of cancer in the OR and helping preserve healthy tissue, Fast Company August 28 reports. Cytalux is an FDA-approved fluorescent agent that makes cancer cells glow green under infrared light, allowing surgeons to spot and remove malignant lesions with…

Read More

By: Tarsilla Moura
September 2, 2025
Share

Robotic surgery boosts 3-year relapse-free survival in rectal cancer

Editor's Note Robotic surgery improves 3-year relapse-free survival compared with laparoscopic surgery for rectal cancer, according to findings presented at the 2025 annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons, published by Gastroenterology & Endoscopy News on August 18. As detailed in the article, researchers conducted a…

Read More

By: Tarsilla Moura
August 28, 2025
Share

Report: Sicker surgical patients fared better post-pandemic

Editor's Note Hospitals achieved a substantial reduction in mortality risk for surgical inpatients between 2019 and 2024, even as patients grew sicker and stayed longer, according to a report released August 5 by the American Hospital Association (AHA) and Vizient. In the first quarter of 2024, hospitalized surgical patients were…

Read More

By: Matt Danford
August 6, 2025
Share

Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows

Editor's Note According to results from a randomized trial, titled KEYNOTE-689, adding pembrolizumab (Keytruda) to surgery and standard adjuvant therapy significantly prolongs event-free survival (EFS) in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC), MedPage Today April 28 reports. Experts are calling the findings a major…

Read More

By: Tarsilla Moura
April 29, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat